Maria del Mar Castro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maria del Mar Castro has a total of 244 co-authors. Here are the top co-authors by number of shared publications:
- Claudia Maria Denkinger
Department of Infectious Diseases and Tropical Medicine, University Hospital Heidelberg, Heidelberg, Germany
12 shared publications - Alexandra Cossio
Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia
11 shared publications - Andrew D. Kerkhoff
Division of HIV, Infectious Diseases, and Global Medicine, Zuckerberg San Francisco General Hospital and Trauma Center, University of California San Francisco, San Francisco, CA, USA
9 shared publications - Neal Alexander
MRC International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine , London
7 shared publications - Adithya Cattamanchi
Center for Tuberculosis, Institute for Global Health Sciences, University of California San Francisco , San Francisco, California
5 shared publications - Nancy Gore Saravia
Centro Internacional de Entrenamiento e Investigaciones Médicas (CIDEIM), Cali, Colombia
5 shared publications
Latest Publications
- Open Access
- 19 June 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
“That is why I trust”: a qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia
Background: Millions of tuberculosis (TB) cases are estimated to be undiagnosed and unreported annually. Sputum has been the primary approach for diagnostic testing, but tongue swabs are being investigated as an alternative to expand testing. To understand potential uptake and implementation, we explored the acceptability, usability, and feasibility of tongue swab-based TB testing from the perspectives of healthcare workers, people undergoing TB screening, and caregivers in Viet Nam and Zambia. Methods: We interviewed people with symptoms of TB, caregivers of children undergoing TB evaluation, and healthcare workers who collected tongue swabs ( n = 76 participants) between September 2023 and February 2024. Interviews were analyzed using framework analysis to elucidate preferences, experiences, and acceptability of tongue swabs vs. sputum. Findings were further organized according to acceptability and feasibility to understand barriers and facilitators to uptake. Results: Most participants preferred tongue swab to sputum collection. The perceived usability and feasibility of tongue swabs were high. Key themes that influenced the acceptability of tongue swabs included ease of use, diagnostic accuracy, diagnostic yield, hygiene, risk of TB transmission during sample collection, time to test result, and trust in healthcare workers and the health system. Across interviews, many participants described tongue swabs as a comfortable and easy way to test for TB, compared to the physical discomfort and difficulty expectorating sputum. Participants described tongue swabs as suitable for everyone, yet perceived diagnostic accuracy was crucial in shaping test preference. Conclusion: Tongue swab-based testing for TB is likely to be highly acceptable and feasible if incorporated into TB diagnostic guidelines. Future integration of tongue swabs in facilities and communities should target drivers of acceptability.
- 19 June 2026
- Published by Springer Nature in BMC Health Services Research
- Vol. 26 (1)
Open Access“That is why I trust”: a qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia
Background: Millions of tuberculosis (TB) cases are estimated to be undiagnosed and unreported annually. Sputum has been the primary approach for diagnostic testing, but tongue swabs are being investigated as an alternative to expand testing. To understand potential uptake and implementation, we explored the acceptability, usability, and feasibility of tongue swab-based TB testing from the perspectives of healthcare workers, people undergoing TB screening, and caregivers in Viet Nam and Zambia. Methods: We interviewed people with symptoms of TB, caregivers of children undergoing TB evaluation, and healthcare workers who collected tongue swabs ( n = 76 participants) between September 2023 and February 2024. Interviews were analyzed using framework analysis to elucidate preferences, experiences, and acceptability of tongue swabs vs. sputum. Findings were further organized according to acceptability and feasibility to understand barriers and facilitators to uptake. Results: Most participants preferred tongue swab to sputum collection. The perceived usability and feasibility of tongue swabs were high. Key themes that influenced the acceptability of tongue swabs included ease of use, diagnostic accuracy, diagnostic yield, hygiene, risk of TB transmission during sample collection, time to test result, and trust in healthcare workers and the health system. Across interviews, many participants described tongue swabs as a comfortable and easy way to test for TB, compared to the physical discomfort and difficulty expectorating sputum. Participants described tongue swabs as suitable for everyone, yet perceived diagnostic accuracy was crucial in shaping test preference. Conclusion: Tongue swab-based testing for TB is likely to be highly acceptable and feasible if incorporated into TB diagnostic guidelines. Future integration of tongue swabs in facilities and communities should target drivers of acceptability.
- Open Access
- 11 May 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (5) , e019902
User perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and Tanzania
Background: Timely and appropriate diagnosis and treatment are key to ending tuberculosis (TB). Incorporating users’ preferences when implementing decentralised strategies for diagnosis may facilitate scale-up and impact. This qualitative study embedded within a cluster randomised controlled trial explored the values and preferences of multiple stakeholders regarding a TB diagnostic strategy using the Truenat platform, mycobacterium tuberculosis (MTB) Plus and rifampicin Dx Assays in Mozambique and Tanzania. Methods: We conducted semi-structured interviews with people with presumptive TB (n=35), professional users (laboratory technicians, nurses, clinicians, n=19) and national decision-makers (n=5). Direct observations of testing procedures and usability surveys (n=12) were also conducted. Thematic analysis was performed, informed by the Consolidated Framework for Implementation Research. Results: Facilities varied in testing capacity, number of cases and time-to-results (from same-day to >2 weeks). Availability and supply of reagents and cartridges were described as an issue by healthcare providers and a potential cause for delayed results. The Truenat platform for detection of TB was considered easy to use (median SUS score 90/100) as well as acceptable and fit to the context where the evaluation was conducted. Truenat’s advantage was appreciated in facilities with limited prior testing capacity (eg, shipping samples, using microscopy), including short time-to-results, reduced need to return to provide more samples and fewer infrastructure needs (compared with GeneXpert). People with presumptive TB preferred the same-day results and rapid initiation of treatment enabled by Truenat testing. Some viewed waiting longer time (>1 day) for the results acceptable if it were to result in increased accuracy. Regarding the diagnostic process, participants valued the support and counselling from the healthcare workers. Conclusions: The Truenat platform and TB assays were perceived as easy to use by health providers, and as acceptable and feasible across stakeholder groups. Its implementation in decentralised settings was considered a preferred alternative to off-site Xpert testing for TB in Mozambique and Tanzania. Trial registration number: NCT04568954 .
- 11 May 2026
- Published by BMJ in BMJ Global Health
- Vol. 11 (5) , e019902
Open AccessUser perspectives on the Molbio Truenat platform and tuberculosis assays for decentralised testing in Mozambique and Tanzania
Background: Timely and appropriate diagnosis and treatment are key to ending tuberculosis (TB). Incorporating users’ preferences when implementing decentralised strategies for diagnosis may facilitate scale-up and impact. This qualitative study embedded within a cluster randomised controlled trial explored the values and preferences of multiple stakeholders regarding a TB diagnostic strategy using the Truenat platform, mycobacterium tuberculosis (MTB) Plus and rifampicin Dx Assays in Mozambique and Tanzania. Methods: We conducted semi-structured interviews with people with presumptive TB (n=35), professional users (laboratory technicians, nurses, clinicians, n=19) and national decision-makers (n=5). Direct observations of testing procedures and usability surveys (n=12) were also conducted. Thematic analysis was performed, informed by the Consolidated Framework for Implementation Research. Results: Facilities varied in testing capacity, number of cases and time-to-results (from same-day to >2 weeks). Availability and supply of reagents and cartridges were described as an issue by healthcare providers and a potential cause for delayed results. The Truenat platform for detection of TB was considered easy to use (median SUS score 90/100) as well as acceptable and fit to the context where the evaluation was conducted. Truenat’s advantage was appreciated in facilities with limited prior testing capacity (eg, shipping samples, using microscopy), including short time-to-results, reduced need to return to provide more samples and fewer infrastructure needs (compared with GeneXpert). People with presumptive TB preferred the same-day results and rapid initiation of treatment enabled by Truenat testing. Some viewed waiting longer time (>1 day) for the results acceptable if it were to result in increased accuracy. Regarding the diagnostic process, participants valued the support and counselling from the healthcare workers. Conclusions: The Truenat platform and TB assays were perceived as easy to use by health providers, and as acceptable and feasible across stakeholder groups. Its implementation in decentralised settings was considered a preferred alternative to off-site Xpert testing for TB in Mozambique and Tanzania. Trial registration number: NCT04568954 .
- Open Access
Development and validation of a machine learning model for community-based tuberculosis screening among persons aged ≥ 15 years in South Africa and Zambia
Introduction: Current tuberculosis (TB) screening tools, such as the WHO four-symptom screen (W4SS), lack sufficient sensitivity and specificity for effective community-based active case finding, contributing to both missed diagnoses and unnecessary diagnostic evaluations. This study aimed to develop and validate a machine learning (ML) model to improve TB risk prediction among persons aged ≥15 years in community settings of Zambia and South Africa. Methods: A large, harmonized dataset was created from four community-based TB prevalence surveys in South Africa and Zambia (N=169,813), restricted to individuals not under treatment at the time of survey. A binary reference outcome was defined based on available microbiological and radiographic data, grouping individuals as either ‘Possible TB’ or ‘Unlikely TB’. An XGBoost model was trained on 80% (N=135,854) of the data using demographic, clinical, and socio-economic variables, and model interpretability was assessed using SHapley Additive exPlanations (SHAP) values. Internal validation was performed using a 20% hold-out test set (N=33,959). Model performance was assessed using discrimination, calibration, and clinical utility measures compared to the W4SS and against WHO’s 2025 Target Product Profile (TPP) for a tool in a two-step screening algorithm. Results: Overall, 16,413 (9.7%) of individuals were labelled as ‘Possible TB’. On the test set, the XGBoost model yielded an area under the curve (AUC) of 79.7% (95% CI: 78.7, 80.7), outperforming the W4SS (AUC 57.0%; 95% CI: 56.1, 57.8). The XGBoost model achieved 81.5% sensitivity (95% CI: 77.6, 84.9) at a 60% specificity threshold. This exceeded the W4SS, which achieved only 38.2% sensitivity (95% CI: 36.5, 39.9) on the same dataset. SHAP analysis identified age, previous TB treatment, times treated for TB and unemployment as the primary contributors to risk. Conclusion: The ML XGBoost model shows promise as a screening tool to support community-based active case finding activities prior to diagnostic testing. However, as performance remained below TPP targets, and adding variables, e.g. on geolocation, could be considered.
Open AccessDevelopment and validation of a machine learning model for community-based tuberculosis screening among persons aged ≥ 15 years in South Africa and Zambia
Introduction: Current tuberculosis (TB) screening tools, such as the WHO four-symptom screen (W4SS), lack sufficient sensitivity and specificity for effective community-based active case finding, contributing to both missed diagnoses and unnecessary diagnostic evaluations. This study aimed to develop and validate a machine learning (ML) model to improve TB risk prediction among persons aged ≥15 years in community settings of Zambia and South Africa. Methods: A large, harmonized dataset was created from four community-based TB prevalence surveys in South Africa and Zambia (N=169,813), restricted to individuals not under treatment at the time of survey. A binary reference outcome was defined based on available microbiological and radiographic data, grouping individuals as either ‘Possible TB’ or ‘Unlikely TB’. An XGBoost model was trained on 80% (N=135,854) of the data using demographic, clinical, and socio-economic variables, and model interpretability was assessed using SHapley Additive exPlanations (SHAP) values. Internal validation was performed using a 20% hold-out test set (N=33,959). Model performance was assessed using discrimination, calibration, and clinical utility measures compared to the W4SS and against WHO’s 2025 Target Product Profile (TPP) for a tool in a two-step screening algorithm. Results: Overall, 16,413 (9.7%) of individuals were labelled as ‘Possible TB’. On the test set, the XGBoost model yielded an area under the curve (AUC) of 79.7% (95% CI: 78.7, 80.7), outperforming the W4SS (AUC 57.0%; 95% CI: 56.1, 57.8). The XGBoost model achieved 81.5% sensitivity (95% CI: 77.6, 84.9) at a 60% specificity threshold. This exceeded the W4SS, which achieved only 38.2% sensitivity (95% CI: 36.5, 39.9) on the same dataset. SHAP analysis identified age, previous TB treatment, times treated for TB and unemployment as the primary contributors to risk. Conclusion: The ML XGBoost model shows promise as a screening tool to support community-based active case finding activities prior to diagnostic testing. However, as performance remained below TPP targets, and adding variables, e.g. on geolocation, could be considered.
- Open Access
- 14 January 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (2) , e395-e398
Predicted Preferences for Tuberculosis Point-of-Care Tests Among Tuberculosis-Affected Individuals in 5 High Burden Countries
Point-of-care (POC) tests are needed to improve tuberculosis (TB) detection, but how TB-affected persons value POC tests is unknown. Simulations using discrete choice experiment-based data from 1149 TB-affected participants across 5 countries demonstrated that POC TB tests were highly preferred, even with modestly lower accuracy compared to standard facility-based testing.
- 14 January 2026
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 83 (2) , e395-e398
Open AccessPredicted Preferences for Tuberculosis Point-of-Care Tests Among Tuberculosis-Affected Individuals in 5 High Burden Countries
Point-of-care (POC) tests are needed to improve tuberculosis (TB) detection, but how TB-affected persons value POC tests is unknown. Simulations using discrete choice experiment-based data from 1149 TB-affected participants across 5 countries demonstrated that POC TB tests were highly preferred, even with modestly lower accuracy compared to standard facility-based testing.
- Open Access
- 20 October 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (10) , e019092
Preferences for tongue swab-based versus sputum-based testing in the context of TB care: a best-worst scaling exercise in Vietnam and Zambia
Background: The development of non-sputum-based tests is an urgent priority to increase access to tuberculosis (TB) diagnostic testing. Understanding preferences of people undergoing testing is critical for designing tests and strategies aligned with their needs. Methods: We conducted a survey and best-worst scaling (BWS) exercise to determine relative preferences for tongue swab-based versus sputum-based testing among people (≥13 years) with presumptive TB at primary health centres in Vietnam and Zambia. The BWS assessed 16 TB test features, including accuracy, sample type, turnaround time, cost and service aspects. We estimated mean rescaled preference weights, our primary outcome, using Hierarchical Bayes modelling and identified distinct preference groups using latent class multinomial logit analyses (LCA). Results: Among 409 participants enrolled, 356 (87%) met quality criteria for analysis. The median age of participants was 39 years (IQR 29–47), and most were female (60.7%). When asked directly, most participants preferred providing tongue swabs over sputum (58.1% vs 28.7%, p<0.001; 12.4% no preference). In the BWS exercise, tongue swab was also preferred over sputum (mean rescaled preference weights (MPWs) 6.4, 95% CI 5.9 to 6.8 vs 5.0 95% CI 4.6 to 5.4). However, support and counselling (MPW=14.0), sensitivity (MPW=12.3), specificity (MPW=10.2) and provider attitude (MPW=7.4) were the most important features overall. Less important features included facility opening hours (MPW=3.4) and the influence of trusted sources on testing decisions (MPW=2.2). LCA identified five distinct preference groups, but support and counselling were universally valued. Participants in Groups 2 (27.3%; n=97) and 3 (17.1%; n=61) valued tongue swabs over many other features. Group 5 participants (11%; n=39) strongly valued sputum-based testing. Conclusions: Participants in Vietnam and Zambia preferred tongue swab-based TB testing over sputum. However, sample type was less important than test accuracy and other TB care features affecting the testing experience.
- 20 October 2025
- Published by BMJ in BMJ Global Health
- Vol. 10 (10) , e019092
Open AccessPreferences for tongue swab-based versus sputum-based testing in the context of TB care: a best-worst scaling exercise in Vietnam and Zambia
Background: The development of non-sputum-based tests is an urgent priority to increase access to tuberculosis (TB) diagnostic testing. Understanding preferences of people undergoing testing is critical for designing tests and strategies aligned with their needs. Methods: We conducted a survey and best-worst scaling (BWS) exercise to determine relative preferences for tongue swab-based versus sputum-based testing among people (≥13 years) with presumptive TB at primary health centres in Vietnam and Zambia. The BWS assessed 16 TB test features, including accuracy, sample type, turnaround time, cost and service aspects. We estimated mean rescaled preference weights, our primary outcome, using Hierarchical Bayes modelling and identified distinct preference groups using latent class multinomial logit analyses (LCA). Results: Among 409 participants enrolled, 356 (87%) met quality criteria for analysis. The median age of participants was 39 years (IQR 29–47), and most were female (60.7%). When asked directly, most participants preferred providing tongue swabs over sputum (58.1% vs 28.7%, p<0.001; 12.4% no preference). In the BWS exercise, tongue swab was also preferred over sputum (mean rescaled preference weights (MPWs) 6.4, 95% CI 5.9 to 6.8 vs 5.0 95% CI 4.6 to 5.4). However, support and counselling (MPW=14.0), sensitivity (MPW=12.3), specificity (MPW=10.2) and provider attitude (MPW=7.4) were the most important features overall. Less important features included facility opening hours (MPW=3.4) and the influence of trusted sources on testing decisions (MPW=2.2). LCA identified five distinct preference groups, but support and counselling were universally valued. Participants in Groups 2 (27.3%; n=97) and 3 (17.1%; n=61) valued tongue swabs over many other features. Group 5 participants (11%; n=39) strongly valued sputum-based testing. Conclusions: Participants in Vietnam and Zambia preferred tongue swab-based TB testing over sputum. However, sample type was less important than test accuracy and other TB care features affecting the testing experience.
- Open Access
- 5 September 2025
- Published by Elsevier in The Lancet Primary Care
- Vol. 1 (3)
Preferences for tuberculosis diagnostic test features among people tested for tuberculosis: a multicountry discrete choice experiment
- 5 September 2025
- Published by Elsevier in The Lancet Primary Care
- Vol. 1 (3)
Open AccessPreferences for tuberculosis diagnostic test features among people tested for tuberculosis: a multicountry discrete choice experiment
- Open Access
Current practices for assessing usability of novel point-of-care diagnostics for infectious diseases: a scoping review protocol
Introduction Novel diagnostics, particularly point-of-care (POC) tests, play a crucial role in the early detection and management of infectious diseases, especially in resource-limited settings. Ensuring test performance and quality while minimising the risk of human error becomes more relevant when shifting testing tasks from highly controlled settings like centralised laboratories to people with minimal training. Applying usability and human factors engineering principles can reduce the challenges related to human errors. Despite existing frameworks and tools, the practical application of usability guidelines remains variable across different settings. Methods and analysis This scoping review protocol outlines a systematic investigation of current practices in assessing the usability of novel diagnostics, particularly POC tests for infectious diseases intended for use in low-income and middle-income countries. The review will analyse original research studies of all designs and product dossiers that report on the usability evaluation or validation of a diagnostic test for an infectious disease. A qualitative synthesis of the data extracted from the articles will be conducted. We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols and the Joanna Briggs Institute guidelines for this scoping review. Ethics and dissemination No ethical approval is required because individual patient data will not be included. The findings will be disseminated through publication in a peer-reviewed journal.
Open AccessCurrent practices for assessing usability of novel point-of-care diagnostics for infectious diseases: a scoping review protocol
Introduction Novel diagnostics, particularly point-of-care (POC) tests, play a crucial role in the early detection and management of infectious diseases, especially in resource-limited settings. Ensuring test performance and quality while minimising the risk of human error becomes more relevant when shifting testing tasks from highly controlled settings like centralised laboratories to people with minimal training. Applying usability and human factors engineering principles can reduce the challenges related to human errors. Despite existing frameworks and tools, the practical application of usability guidelines remains variable across different settings. Methods and analysis This scoping review protocol outlines a systematic investigation of current practices in assessing the usability of novel diagnostics, particularly POC tests for infectious diseases intended for use in low-income and middle-income countries. The review will analyse original research studies of all designs and product dossiers that report on the usability evaluation or validation of a diagnostic test for an infectious disease. A qualitative synthesis of the data extracted from the articles will be conducted. We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols and the Joanna Briggs Institute guidelines for this scoping review. Ethics and dissemination No ethical approval is required because individual patient data will not be included. The findings will be disseminated through publication in a peer-reviewed journal.
- Open Access
Informing People-Centered Target Product Profiles for TB Diagnostics: A Multi-Country Qualitative Study
Background: Timely and accurate tuberculosis (TB) diagnosis remains a key challenge in high-burden settings. The World Health Organization (WHO) has developed Target Product Profiles (TPPs) to guide diagnostic development, which have largely reflected the perspectives of experts, with limited input from people affected by TB. This qualitative study explored preferences and experiences to inform people-centered TB diagnostic strategies. Methods: We conducted 75 semi-structured interviews with adults undergoing TB evaluation at outpatient clinics in India, the Philippines, South Africa, Uganda, and Vietnam. Participants were purposively sampled to ensure diversity in sex, TB status, age and treatment. Thematic analysis was utilized. Findings: Preferences were shaped by five interrelated domains: perceived diagnostic accuracy, sample collection experience, time-to-results, affordability, and testing location. Diagnostic accuracy was consistently prioritized, with many expressing willingness to trade comfort and convenience for more trustworthy results. Sputum and blood were widely trusted despite collection challenges, whereas tongue swabs and urine were easier to provide but perceived as less accurate. Rapid, same-day turnaround was valued for minimizing emotional distress, financial and logistical burdens. Although testing was typically free, indirect costs such as transport and lost income, remained barriers. Hospital-based testing was preferred due to trust in staff and infrastructure, though some acknowledged the appeal of community-based approaches if reliability and privacy were ensured. Conclusion: People seeking TB care prioritize accuracy and trustworthiness, even at the expense of comfort or convenience. These preferences can inform WHO policy updates, especially regarding the adoption of novel sample types and testing strategies, to support uptake and equitable access to novel diagnostics.
Open AccessInforming People-Centered Target Product Profiles for TB Diagnostics: A Multi-Country Qualitative Study
Background: Timely and accurate tuberculosis (TB) diagnosis remains a key challenge in high-burden settings. The World Health Organization (WHO) has developed Target Product Profiles (TPPs) to guide diagnostic development, which have largely reflected the perspectives of experts, with limited input from people affected by TB. This qualitative study explored preferences and experiences to inform people-centered TB diagnostic strategies. Methods: We conducted 75 semi-structured interviews with adults undergoing TB evaluation at outpatient clinics in India, the Philippines, South Africa, Uganda, and Vietnam. Participants were purposively sampled to ensure diversity in sex, TB status, age and treatment. Thematic analysis was utilized. Findings: Preferences were shaped by five interrelated domains: perceived diagnostic accuracy, sample collection experience, time-to-results, affordability, and testing location. Diagnostic accuracy was consistently prioritized, with many expressing willingness to trade comfort and convenience for more trustworthy results. Sputum and blood were widely trusted despite collection challenges, whereas tongue swabs and urine were easier to provide but perceived as less accurate. Rapid, same-day turnaround was valued for minimizing emotional distress, financial and logistical burdens. Although testing was typically free, indirect costs such as transport and lost income, remained barriers. Hospital-based testing was preferred due to trust in staff and infrastructure, though some acknowledged the appeal of community-based approaches if reliability and privacy were ensured. Conclusion: People seeking TB care prioritize accuracy and trustworthiness, even at the expense of comfort or convenience. These preferences can inform WHO policy updates, especially regarding the adoption of novel sample types and testing strategies, to support uptake and equitable access to novel diagnostics.
- Open Access
Preferences for Tongue Swab versus Sputum Collection for Tuberculosis Testing: A Multi-Country Survey
Background Sputum collection for tuberculosis (TB) diagnosis poses challenges for children, people living with HIV, and those who struggle with sputum production. Tongue swab-based molecular testing offers a promising non-invasive alternative, but person-centered research on acceptability is limited. Methods We conducted a pragmatic survey across eight countries (Vietnam, Philippines, South Africa, Nigeria, Zambia, India, Uganda, Peru) among people with presumptive TB attending primary care facilities. Participants provided both tongue swab and sputum samples, then completed a 5-10 minute survey about their collection preferences. Results From October 2023 to July 2024, 1,297 participants were enrolled (median age 43 years, 45% female, 13% HIV-positive). Overall, 61% (95% CI: 58-64%) preferred tongue swab collection compared to 22% (95% CI: 20-25%) who preferred sputum collection and 17% (95% CI: 15-19%) with no preference. Preference for tongue swab was consistent across demographic and clinical subgroups, with country-level variation ranging from 47% in South Africa to 74% in Zambia and Nigeria. Conclusion Strong preference for tongue swab over sputum collection among individuals with presumptive TB supports this diagnostic innovation’s potential to overcome barriers to timely TB testing, particularly for populations struggling with sputum production.
Open AccessPreferences for Tongue Swab versus Sputum Collection for Tuberculosis Testing: A Multi-Country Survey
Background Sputum collection for tuberculosis (TB) diagnosis poses challenges for children, people living with HIV, and those who struggle with sputum production. Tongue swab-based molecular testing offers a promising non-invasive alternative, but person-centered research on acceptability is limited. Methods We conducted a pragmatic survey across eight countries (Vietnam, Philippines, South Africa, Nigeria, Zambia, India, Uganda, Peru) among people with presumptive TB attending primary care facilities. Participants provided both tongue swab and sputum samples, then completed a 5-10 minute survey about their collection preferences. Results From October 2023 to July 2024, 1,297 participants were enrolled (median age 43 years, 45% female, 13% HIV-positive). Overall, 61% (95% CI: 58-64%) preferred tongue swab collection compared to 22% (95% CI: 20-25%) who preferred sputum collection and 17% (95% CI: 15-19%) with no preference. Preference for tongue swab was consistent across demographic and clinical subgroups, with country-level variation ranging from 47% in South Africa to 74% in Zambia and Nigeria. Conclusion Strong preference for tongue swab over sputum collection among individuals with presumptive TB supports this diagnostic innovation’s potential to overcome barriers to timely TB testing, particularly for populations struggling with sputum production.
- Open Access
“That is why I trust”: A qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia
Millions of tuberculosis (TB) cases are estimated to be undiagnosed and unreported annually. Sputum has been the primary approach for diagnostic testing but tongue swabs are being investigated as an alternative to expand testing. To understand potential uptake and implementation, we explored the acceptability, usability, and feasibility of tongue swab-based TB testing from the perspective of healthcare workers, people undergoing TB screening, and caregivers in Viet Nam and Zambia. We interviewed people with symptoms of TB, caregivers of children undergoing TB evaluation, and healthcare workers who collected tongue swabs (n = 76 participants) between September 2023 and February 2024. Interviews were analyzed using framework analysis to elucidate preferences, experiences, and acceptability of tongue swabs vs. sputum. Findings were further organized according to acceptability and feasibility to understand barriers and facilitators to uptake. Most participants preferred tongue swab to sputum collection. The perceived usability and feasibility of tongue swabs were high. Key themes that influenced the acceptability of tongue swabs included ease of use, diagnostic accuracy, diagnostic yield, hygiene, risk of TB transmission during sample collection, time to test result, and trust in healthcare workers and the health system. Across interviews, many participants described tongue swabs as a comfortable and easy way to test for TB, compared to the physical discomfort and difficulty expectorating sputum. Participants described tongue swab suitability for everyone, yet perceived diagnostic accuracy was crucial in shaping test preference. Tongue swab-based testing for TB is likely to be highly acceptable and feasible if incorporated into TB diagnostic guidelines.
Open Access“That is why I trust”: A qualitative study on acceptability and feasibility of novel tongue swab diagnostics to assess people presenting with tuberculosis symptoms in Viet Nam and Zambia
Millions of tuberculosis (TB) cases are estimated to be undiagnosed and unreported annually. Sputum has been the primary approach for diagnostic testing but tongue swabs are being investigated as an alternative to expand testing. To understand potential uptake and implementation, we explored the acceptability, usability, and feasibility of tongue swab-based TB testing from the perspective of healthcare workers, people undergoing TB screening, and caregivers in Viet Nam and Zambia. We interviewed people with symptoms of TB, caregivers of children undergoing TB evaluation, and healthcare workers who collected tongue swabs (n = 76 participants) between September 2023 and February 2024. Interviews were analyzed using framework analysis to elucidate preferences, experiences, and acceptability of tongue swabs vs. sputum. Findings were further organized according to acceptability and feasibility to understand barriers and facilitators to uptake. Most participants preferred tongue swab to sputum collection. The perceived usability and feasibility of tongue swabs were high. Key themes that influenced the acceptability of tongue swabs included ease of use, diagnostic accuracy, diagnostic yield, hygiene, risk of TB transmission during sample collection, time to test result, and trust in healthcare workers and the health system. Across interviews, many participants described tongue swabs as a comfortable and easy way to test for TB, compared to the physical discomfort and difficulty expectorating sputum. Participants described tongue swab suitability for everyone, yet perceived diagnostic accuracy was crucial in shaping test preference. Tongue swab-based testing for TB is likely to be highly acceptable and feasible if incorporated into TB diagnostic guidelines.